GALMED PHARMACEUTICALS LTD. Payments to Acquire Available-for-sale Securities
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments to Acquire Available-for-sale Securities of $68.72 million for the 6-month period ending 2019-06-30, per its 6-K filed 2019-08-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2019-08-05
| Period end | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|
| 2019-06-30 | $68.72M 6-K · filed 2019-08-05 | |
| 2018-12-31 | $92.28M 20-F · filed 2019-03-13 | |
| 2018-06-30 | $85.17M 6-K · filed 2019-08-05 | |
| 2017-12-31 | $3.87M 20-F · filed 2019-03-13 | |
| 2017-06-30 | $0.00 6-K · filed 2018-08-02 | |
| 2016-12-31 | $7.62M 20-F · filed 2019-03-13 | |
| 2016-06-30 | $1.21M 6-K · filed 2017-07-31 | |
| 2015-12-31 | $26.54M 20-F · filed 2018-03-13 | |
| 2015-06-30 | $21.84M 6-K · filed 2017-06-23 | |
| 2014-12-31 | $2.25M 20-F · filed 2017-03-23 | |
| 2013-12-31 | $0.00 20-F · filed 2016-03-22 | |
| 2012-12-31 | $0.00 20-F · filed 2015-03-31 |